<DOC>
	<DOCNO>NCT01570634</DOCNO>
	<brief_summary>Clostridium difficile ( C. difficile ) cause symptom range mild diarrhea life-threatening colitis . Illness C. difficile commonly affect patient hospital long-term care facility typically occur patient receive antibiotic . In vitro data indicate Calcium Aluminosilicate Anti-Diarrheal ( CASAD ) potential bind TNFÎ± , IL-1 , IL-6 , IL-10 intestine , therefore , may act reduce severity fever , leukocytosis , bowel injury patient C. difficile infection . This would likely occur conjunction neutralization C. difficile toxins A &amp; B CASAD . Computer model CASAD perform Phillips et al . Texas A &amp; M University support hypothesis . The investigator hypothesize add CASAD 1.5 gram po tid standard-of-care therapy reduce duration severity diarrhea symptom patient C. difficile infection .</brief_summary>
	<brief_title>Proof-of-Concept , Calcium Aluminosilicate Anti-Diarrheal ( CASAD ) Treatment Clostridium Difficile Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<criteria>C. difficileassociated diarrhea time enrollment 18 year old Ability take oral medication Negative urine pregnancy test woman childbearing age Must ability understand willingness provide write informed consent participate study History know allergy silicates Patients sign toxic megacolon , peritonitis , pseudomembranous colitis bowel perforation Patients hypotension ( systolic blood pressure &lt; 90 mm Hg ) septic shock require pressor Patients know cause diarrhea colitis Pregnancy lactation History significant neurological psychiatric disorder would impede give consent , treatment , follow Participation study subject actively take investigational medication within last 30 day More 5 dos metronidazole oral vancomycin prior start study drug current C. difficile diagnosis . Administration metronidazole oral vancomycin treatment prior C. difficile diagnosis exclusionary patient may experience relapse C. difficile . Any antibiotic , toxinbinding agent fecal transplant use treatment C. difficile prior add subject 's standardofcare treatment regimen . Use intravenous vancomycin exclusionary .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Clostridium difficile</keyword>
	<keyword>infection</keyword>
	<keyword>diarrhea</keyword>
	<keyword>cramp</keyword>
</DOC>